Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Endpoint summary

Currently viewing:

Administrative data

Description of key information

Key study: Equivalent to EU method B.6. No data on GLP.


A Magnusson and Kligman maximisation test was performed to determine the sensitising potential of the test substance. The percentage of animals showing a positive response after treatment with the test substance was ≥35% in all the test groups. The substance is considered to be a skin sensitiser.


 


Justification for selection of skin sensitisation endpoint:


Klimisch 2. Equivalent to EU method B.6. No data on GLP.

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Equivalent to EU method B.6. No data on GLP.
Qualifier:
equivalent or similar to guideline
Guideline:
EU Method B.6 (Skin Sensitisation)
Deviations:
no
Principles of method if other than guideline:
Magnusson and Kligman maximisation test
GLP compliance:
not specified
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
An appropriate guinea pig maximisation test is available which would not justify conducting an additional LLNA due to animal welfare.
Species:
guinea pig
Strain:
Dunkin-Hartley
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Charles River
- Weight at study initiation: 350 g
- Housing: The animals were housed individually in polypropylene cages
- Diet (e.g. ad libitum): Sterilized granules (UAR 114); ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: one week

ENVIRONMENTAL CONDITIONS
- Temperature (°C):20 ± 1 ºC
- Humidity (%): 50 ± 5%
- Air changes (per hr): 15 cycles/hour
- Photoperiod (hrs dark / hrs light): light - dark cycle 12 h:12 h
Route:
intradermal and epicutaneous
Concentration / amount:
Nº1:
Induction: 1 and 3 % p/v (in water)
Challenge: 0.5 % p/v (in water)

Nº2:
Induction: 1 and 3 % p/v (in water)
Challenge: 0.5 % p/v (in water)

Nº3:
Induction: 0.5 and 3 % p/v (in propylene glycol)
Challenge: 0.5 % p/v (in propylene glycol)

Nº4:
Induction: 0.3 and 1 % p/v (in water)
Challenge: 1 % p/v (in water)
Route:
epicutaneous, occlusive
Concentration / amount:
Nº1:
Induction: 1 and 3 % p/v (in water)
Challenge: 0.5 % p/v (in water)

Nº2:
Induction: 1 and 3 % p/v (in water)
Challenge: 0.5 % p/v (in water)

Nº3:
Induction: 0.5 and 3 % p/v (in propylene glycol)
Challenge: 0.5 % p/v (in propylene glycol)

Nº4:
Induction: 0.3 and 1 % p/v (in water)
Challenge: 1 % p/v (in water)
No. of animals per dose:
Treatment: 20 animals
Control: 10 animals
Details on study design:
RANGE FINDING TESTS:
The concentrations used in the main study were established in a preliminary study to determine the lowest concentrations producing low irritation for the induction phase and the highest non irritant concentrations for the challenge phase.

MAIN STUDY
A. INDUCTION EXPOSURE
Day 1:
Three pairs of intradermal injections of 0.1 ml are given in the shoulder region.
Injection 1: the test substance in an appropriate vehicle at the selected concentration
Injection 2: a 1:1 mixture (v/v) FCA/physiological saline
Injection 3: the test substance at the selected concentration formulated in a 1:1 mixture (v/v) FCA/physiological saline.

Day 8: The substance is applied to the treated area (occlusive) at a slightly irritant concentration for 48 hours.

The control group is treated with the vehicle and FCA following the same conditions as for the treated group.

B. CHALLENGE EXPOSURE
- Day(s) of challenge: Day 22
- Exposure period: 24 h
- Concentrations: 0.5 ml of the test substance at the highest non irritant concentration (occlusive)
- Evaluation (hr after challenge): 24 and 48 h

Positive control substance(s):
yes
Remarks:
(α-hexylcinnamaldehyde (HCA), CAS No. 101-86-0)
Positive control results:
The percentage of animals showing a positive response was 31% (6/19).
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
Induction: 1 and 3 % p/v (in water)
Challenge: 0.5 % p/v (in water)
No. with + reactions:
13
Total no. in group:
20
Remarks on result:
other: Test group Nº1
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
Induction: 1 and 3 % p/v (in water)
Challenge: 0.5 % p/v (in water)
No. with + reactions:
18
Total no. in group:
20
Remarks on result:
other: Test group Nº2
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
Induction: 0.5 and 3 % p/v (in propylene glycol)
Challenge: 0.5 % p/v (in propylene glycol)
No. with + reactions:
12
Total no. in group:
19
Remarks on result:
other: Test group Nº3
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
Induction: 0.3 and 1 % p/v (in water)
Challenge: 1 % p/v (in water)
No. with + reactions:
7
Total no. in group:
20
Remarks on result:
other: Test group Nº4

The percentage of animals showing a positive response after treatment with the test substance was ≥35% in all the test groups.

Interpretation of results:
Category 1A (indication of significant skin sensitising potential) based on GHS criteria
Conclusions:
The percentage of animals showing a positive response after treatment with the test substance was ≥35% in all the test groups. The substance is considered to be a skin sensitiser.
Executive summary:

A Magnusson and Kligman maximisation test was performed to determine the sensitising potential of the test substance.

The percentage of animals showing a positive response after treatment with the test substance was ≥35% in all the test groups. The substance is considered to be a skin sensitiser.
Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

Key study: Equivalent to EU method B.6. No data on GLP.


A Magnusson and Kligman maximisation test was performed to determine the sensitising potential of the test substance. The percentage of animals showing a positive response after treatment with the test substance was ≥35% in all the test groups. The substance is considered to be a skin sensitiser.

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Based on the available data, the substance is classified as Skin sensitiser Category 1A.

Guinea pig maximisation test:

≥ 30 % responding at ≤ 0,1 % intradermal induction dose or

≥ 60 % responding at > 0,1 % to ≤ 1 % intradermal induction dose